Viewing Study NCT04643158


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-05-18 @ 4:03 PM
Study NCT ID: NCT04643158
Status: TERMINATED
Last Update Posted: 2025-08-28
First Post: 2020-11-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AZD1402 View
None placebo View
None Anticalin® protein View
None dry powder inhaler View
None inhaled corticosteroids View
None efficacy View
None safety View